Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT04789551

T Cell Profiling in Patients with Multiple Sclerosis

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
13 Years – 20 Years
Healthy volunteers
Not accepted

Summary

The goal of this research study is to to learn more about the body's immune response in patients with multiple sclerosis (MS). In MS, the body's immune cells mistakenly attack an important part of the nerves of the brain and spinal cord. The immune cells responsible for attacking the nerves in MS patients is primarily the T cells. A marker was recently discovered that might specifically identify these damaging T cells from all other T cells in the body. Understanding which T cells cause the damage in MS patients and understanding more about these specific T cells may help doctors better understand how MS occurs and could possibly prevent MS in the future.

Conditions

Interventions

TypeNameDescription
OTHERBlood Samplea blood sample will be collected

Timeline

Start date
2025-06-01
Primary completion
2025-07-01
Completion
2025-12-01
First posted
2021-03-09
Last updated
2025-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04789551. Inclusion in this directory is not an endorsement.

T Cell Profiling in Patients with Multiple Sclerosis (NCT04789551) · Clinical Trials Directory